Table 1. Baseline characteristics of the population.
| Demographics | SLT group (n=64) | Control group (n=61) | P |
| Age (a) | 68.59±12.84 | 72.07±11.79 | 0.17 |
| Sex (M/F) | 33 (51.56)/31 (48.44) | 30 (49.18)/31 (50.82) | 0.47 |
| Risk factors1 | 1.52±0.96 | 1.64±1.32 | 0.13 |
| Glaucoma parameters | |||
| IOP before medication (mm Hg) | 23.21±5.28 | 22.92±4.50 | 0.98 |
| IOP at baseline with medication (mm Hg) | 13.66±3.35 | 12.47±3.31 | 0.07 |
| POAG/OHT | 52 (81.25)/12 (18.75) | 42 (68.85)/19 (31.15) | 0.11 |
| BCVA | 0.85±0.22 | 0.81±0.22 | 0.28 |
| CCT (µm) | 545.66±44.25 | 552.20 ±40.46 | 0.24 |
| Cup disc ratio | 0.83±0.82 | 0.76±0.62 | 0.57 |
| Visual field MD | 5.07±6.04 | 5.23±6.59 | 1.0 |
| Visual field PSD | 4.43±3.31 | 4.59±3.72 | 0.84 |
| OCT FLV | 4.34±4.52 | 4.88±4.67 | 0.52 |
| Medication at start | |||
| Total number | 1.56±0.81 | 1.39±0.67 | 0.57 |
| Prostaglandinanalogs | 59 (92.19) | 48 (78.69) | 0.03 |
| Betablocker | 26 (40.63) | 29 (47.54) | 0.44 |
| Carboanhydrase inhibitor | 10 (15.63) | 6 (9.84) | 0.34 |
| Alphamimetics | 5 (7.81) | 2 (3.28) | 0.27 |
IOP: Intraocular pressure; BCVA: Best corrected visual acuity; POAG: Primary open angle glaucoma; OHT: Ocular hypertension; CCT: Central corneal thickness; MD: Mean deviation; PSD: Pattern standard deviation; OCT: Optical coherence tomography; FLV: Focal loss of volume in %. 1Risk factors: myopia, hypertension, diabetes, migraine, vascular problems, family history of glaucoma.
n (%)